{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T01:48:48Z","timestamp":1782092928288,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02131-3","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:33:51Z","timestamp":1777642431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical value of VI-RADS score in predicting repeat transurethral resection in primary bladder cancer: a prospective observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Anar","family":"Aghayev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin Mert","family":"Durak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Hep\u015fen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Din\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Raif","family":"Karabacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"1","key":"2131_CR1","first-page":"15","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiol Bladder Cancer Med Sci (Basel). 2020;8(1):15.","journal-title":"Epidemiol Bladder Cancer Med Sci (Basel)"},{"issue":"8","key":"2131_CR2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895\u2013904.","journal-title":"World J Urol"},{"issue":"1","key":"2131_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, Palou J, van Rhijn BWG, Roupr\u00eat M, Shariat SF, Seisen T, Soukup V, Sylvester RJ. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022;81(1):75\u201394.","journal-title":"Eur Urol"},{"issue":"4","key":"2131_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.eururo.2020.06.051","volume":"78","author":"P Mariappan","year":"2020","unstructured":"Mariappan P, Johnston A, Padovani L, Clark E, Trail M, Hamid S, Hollins G, Simpson H, Thomas BG, Hasan R, Bhatt J, Ahmad I, Nandwani GM, Mitchell IDC, Hendry D, for members of the Scottish Bladder Cancer QPI Research Collaborative. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland\u2019s Quality Performance Indicators Programme. Eur Urol. 2020;78(4):520\u201330.","journal-title":"Eur Urol"},{"key":"2131_CR5","doi-asserted-by":"crossref","unstructured":"Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Eur Urol. 2020;77(1):101-109.","DOI":"10.1016\/j.eururo.2019.09.029"},{"issue":"42","key":"2131_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/DEHT5407","volume":"28","author":"N James","year":"2024","unstructured":"James N, Pirrie S, Liu W, Catto J, Jefferson K, Patel P, Hughes A, Pope A, Nanton V, Mintz HP, Knight A, Gallagher J, Bryan RT. Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT. Health Technol Assess. 2024;28(42):1\u201365.","journal-title":"Health Technol Assess"},{"issue":"1","key":"2131_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euf.2023.07.002","volume":"10","author":"T Yanagisawa","year":"2024","unstructured":"Yanagisawa T, Kawada T, von Deimling M, Bekku K, Laukhtina E, Rajwa P, Chlosta M, Pradere B, D\u2019Andrea D, Moschini M, Karakiewicz PI, Teoh JY, Miki J, Kimura T, Shariat SF. Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era. Eur Urol Focus. 2024;10(1):41\u201356.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"2131_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.euo.2020.06.010","volume":"4","author":"H Mostafid","year":"2021","unstructured":"Mostafid H, Kamat AM, Daneshmand S, Palou J, Taylor JA 3rd, McKiernan J, Catto J, Babjuk M, Soloway M. Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. Eur Urol Oncol. 2021;4(1):12\u20139.","journal-title":"Eur Urol Oncol"},{"issue":"9","key":"2131_CR9","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1007\/s00261-017-1449-0","volume":"43","author":"CB van der Pol","year":"2018","unstructured":"van der Pol CB, Shinagare AB, Tirumani SH, Preston MA, Vangel MG, Silverman SG. Bladder cancer local staging: multiparametric MRI performance following transurethral resection. Abdom Radiol (NY). 2018;43(9):2412\u201323.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"2131_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, Huddart R, Kennish S, Lerner S, Montironi R, Muglia VF, Salomon G, Thomas S, Vargas HA, Witjes JA, Takeuchi M, Barentsz J, Catto JWF. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 2018;74(3):294\u2013306.","journal-title":"Eur Urol"},{"issue":"3","key":"2131_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","volume":"3","author":"S Woo","year":"2020","unstructured":"Woo S, Panebianco V, Narumi Y, Del Giudice F, Muglia VF, Takeuchi M, Ghafoor S, Bochner BH, Goh AC, Hricak H, Catto JWF, Vargas HA. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2020;3(3):306\u201315.","journal-title":"Eur Urol Oncol"},{"issue":"9","key":"2131_CR12","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1007\/s00330-021-07765-5","volume":"31","author":"MI Metwally","year":"2021","unstructured":"Metwally MI, Zeed NA, Hamed EM, Elshetry ASF, Elfwakhry RM, Alaa Eldin AM, Sakr A, Aly SA, Mosallam W, Ziada YMA, Balata R, Harb OA, Basha MAA. The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study. Eur Radiol. 2021;31(9):6949\u201361.","journal-title":"Eur Radiol"},{"key":"2131_CR13","doi-asserted-by":"crossref","unstructured":"El-Karamany TM, Al-Adl AM, Hosny MM, Eldeep A, El-Hamshary H. SA. Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: A prospective study. Urol Oncol. 2022;40(10):454.e1-454.e7.","DOI":"10.1016\/j.urolonc.2022.03.008"},{"issue":"10","key":"2131_CR14","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1007\/s00330-019-06117-8","volume":"29","author":"G Barchetti","year":"2019","unstructured":"Barchetti G, Simone G, Ceravolo I, Salvo V, Campa R, Del Giudice F, De Berardinis E, Buccilli D, Catalano C, Gallucci M, Catto JWF, Panebianco V. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center. Eur Radiol. 2019;29(10):5498\u2013506.","journal-title":"Eur Radiol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02131-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02131-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02131-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T01:28:16Z","timestamp":1782091696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02131-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2131"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02131-3","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of Diskapi Yildirim Beyazit Training and Research Hospital (Decision No: 146\/31; Date: 12 September 2022). Written informed consent was obtained from all participants prior to mpMRI.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}